Literature DB >> 11589421

Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation.

M Ito1, B M Blumberg, D J Mock, A D Goodman, A B Moser, H W Moser, K D Smith, J M Powers.   

Abstract

The 2 most common forms of X-linked adreno-leukodystrophy (ALD) are the juvenile or childhood cerebral form with inflammatory demyelination and the adult adrenomyeloneuropathy (AMN) involving spinal cord tracts without significant inflammation. Modifier genes or environmental factors may contribute to the phenotypic variability. We performed immunohistochemical, an in situ polymerase chain reaction, and TUNEL analyses to identify several viruses, lymphocyte subpopulations, apoptotic cells, and effector molecules, focusing on morphologically normal white matter, dysmyelinative and acute demyelinative lesions. No distinguishing viral antigens were detected. Most lymphocytes were CD8 cytotoxic T cells (CTLs) with the alpha/beta TCR, and they infiltrated morphologically unaffected white matter. Only a few oligodendrocytes were immunoreactive for caspase-3. MHC class II- and TGF-beta-positive microglia were present. CD44, which can mediate MHC-unrestricted target cell death, was seen on many lymphocytes and white matter elements. CD1 molecules, which play major roles in MHC-unrestricted lipid antigen presentation, were noted. Our data indicate that unconventional CD8 CTLs are operative in the early stages of dysmyelination/demyelination and that cytolysis of oligodendrocytes, rather than apoptosis, appears to be the major mode of oligodendrocytic death. The presentation of lipid antigens may be a key pathogenetic element in ALD and AMN-ALD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589421     DOI: 10.1093/jnen/60.10.1004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  30 in total

Review 1.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Activated T cells induce proliferation of oligodendrocyte progenitor cells via release of vascular endothelial cell growth factor-A.

Authors:  Elliot H Choi; Yadi Xu; Marie Medynets; Maria Chiara G Monaco; Eugene O Major; Avindra Nath; Tongguang Wang
Journal:  Glia       Date:  2018-11       Impact factor: 7.452

3.  Onset of adreno-leukodystrophy after medulloblastoma therapy: causal connection or coincidence?

Authors:  G Deib; A Poretti; A Meoded; K J Cohen; G V Raymond; M Abromowitch; T A G M Huisman
Journal:  JIMD Rep       Date:  2011-09-06

Review 4.  Role of immune cells in animal models for inherited peripheral neuropathies.

Authors:  Chi Wang Ip; Antje Kroner; Stefan Fischer; Martin Berghoff; Igor Kobsar; Mathias Mäurer; Rudolf Martini
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids.

Authors:  Yumi Tagawa; Wouter Laroy; Leonardo Nimrichter; Susan E Fromholt; Ann B Moser; Hugo W Moser; Ronald L Schnaar
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 6.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

Review 7.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

8.  Regulatory role of CD1d in neurotropic virus infection.

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Robert S Fujinami
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

Review 9.  Therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser
Journal:  NeuroRx       Date:  2006-04

Review 10.  "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Authors:  Hugo W Moser; Ann B Moser; Kim Hollandsworth; N Hong Brereton; Gerald V Raymond
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.